查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1556656

连续压片生产线市场报告：2030 年趋势、预测与竞争分析

Continuous Tableting Line Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

连续压片生产线趋势与预测

预计 2024 年至 2030 年，全球连续压片生产线市场将以 3.6% 的复合年增长率成长。该市场的主要驱动力是个人化医疗和复杂药物配方的日益采用，以及外包製造的成长趋势。全球连续压片生产线市场前景广阔，生物製药、口服固态和保健食品市场充满机会。

分段连续压片生产线

本研究包括按类型、应用和地区对全球连续压片生产线的预测。

连续压片生产线市场洞察

根据Lucintel的预测，连续配方奶粉预计将在预测期内实现高速成长。

在这个市场中，生物製药预计将经历最高的成长。

在预测期内，北美仍将是最大的地区。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球连续压片生产线市场预计将以3.6%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动力是个人化医疗和复杂药物配方的日益普及，以及製造外包的上升趋势。

Q3.市场的主要细分市场是：

A3. 由于生物製药、口服固体製剂和保健食品市场的机会，连续压片生产线市场的未来性广阔。

Q4.市场的主要企业是：

A4. 连续压片生产线主要企业如下：

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon

Q5.未来最大的细分市场是什么？

A5.Lucintel预测连续配方奶粉在预测期间内可望高速成长。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 在预测期内，北美仍将是最大的地区。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球连续压片生产线市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球连续压片生产线市场趋势（2018-2023）与预测（2024-2030）
  • 全球连续压片生产线市场（按类型）
    • 连续式
    • 半连续
  • 按应用分類的全球连续压片生产线市场
    • 生物製药
    • 口服固态剂型
    • 保健品
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球连续压片生产线市场
  • 北美连续压片生产线市场
  • 欧洲连续压片生产线市场
  • 亚太连续压片生产线市场
  • 其他地区连续压片线市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球连续压片生产线市场的成长机会：按类型
    • 全球连续压片生产线市场的成长机会：依应用分类
    • 全球连续压片生产线市场成长机会：按地区
  • 全球连续压片线市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球连续压片生产线市场的产能
    • 全球连续压片生产线市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon
简介目录

Continuous Tableting Line Trends and Forecast

The future of the global continuous tableting line market looks promising with opportunities in the biopharmaceutical, oral solid dosage form, and health products markets. The global continuous tableting line market is expected to grow with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are growing adoption of personalized medicine and complex drug formulations and rising trend of outsourcing manufacturing.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Continuous Tableting Line by Segment

The study includes a forecast for the global continuous tableting line by type, application, and region.

Continuous Tableting Line Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Continuous
  • Semi-continuous

Continuous Tableting Line Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Biopharmaceutical
  • Oral Solid Dosage Form
  • Health Products
  • Others

Continuous Tableting Line Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Continuous Tableting Line Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies continuous tableting line companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the continuous tableting line companies profiled in this report include-

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon

Continuous Tableting Line Market Insights

Lucintel forecasts that continuous is expected to witness higher growth over the forecast period.

Within this market, biopharmaceutical is expected to witness the highest growth.

North America will remain the largest region over the forecast period.

Features of the Global Continuous Tableting Line Market

Market Size Estimates: Continuous tableting line market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Continuous tableting line market size by type, application, and region in terms of value ($B).

Regional Analysis: Continuous tableting line market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the continuous tableting line market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the continuous tableting line market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for continuous tableting line market?

Answer: The global continuous tableting line market is expected to grow with a CAGR of 3.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the continuous tableting line market?

Answer: The major drivers for this market are growing adoption of personalized medicine and complex drug formulations and rising trend of outsourcing manufacturing.

Q3. What are the major segments for continuous tableting line market?

Answer: The future of the continuous tableting line market looks promising with opportunities in the biopharmaceutical, oral solid dosage form, and health products markets.

Q4. Who are the key continuous tableting line market companies?

Answer: Some of the key continuous tableting line companies are as follows:

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon

Q5. Which continuous tableting line market segment will be the largest in future?

Answer: Lucintel forecasts that continuous is expected to witness higher growth over the forecast period.

Q6. In continuous tableting line market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the continuous tableting line market by type (continuous and semi-continuous), application (biopharmaceutical, oral solid dosage form, health products, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Continuous Tableting Line Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Continuous Tableting Line Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Continuous Tableting Line Market by Type
    • 3.3.1: Continuous
    • 3.3.2: Semi-continuous
  • 3.4: Global Continuous Tableting Line Market by Application
    • 3.4.1: Biopharmaceutical
    • 3.4.2: Oral Solid Dosage Form
    • 3.4.3: Health Products
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Continuous Tableting Line Market by Region
  • 4.2: North American Continuous Tableting Line Market
    • 4.2.1: North American Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.2.2: North American Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others
  • 4.3: European Continuous Tableting Line Market
    • 4.3.1: European Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.3.2: European Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others
  • 4.4: APAC Continuous Tableting Line Market
    • 4.4.1: APAC Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.4.2: APAC Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others
  • 4.5: ROW Continuous Tableting Line Market
    • 4.5.1: ROW Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.5.2: ROW Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Continuous Tableting Line Market by Type
    • 6.1.2: Growth Opportunities for the Global Continuous Tableting Line Market by Application
    • 6.1.3: Growth Opportunities for the Global Continuous Tableting Line Market by Region
  • 6.2: Emerging Trends in the Global Continuous Tableting Line Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Continuous Tableting Line Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Continuous Tableting Line Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GEA
  • 7.2: Hovione
  • 7.3: Fette Compacting
  • 7.4: IMA Pharma
  • 7.5: Coperion K-Tron
  • 7.6: KORSCH
  • 7.7: Syntegon